Investor Relations

 

Transcat (Nasdaq:TRNS) has been a leader in the test and measurement industry for over 40 years. We strive to differentiate ourselves and build barriers to competitive entry by offering the best products, delivering high quality calibration and repair services, and integrating those products and services. We work diligently to create lasting value for our shareholders.

Strategy

Our strategy is to continue to grow our business through a blend of organic revenue growth and acquisitions. We leverage the complementary nature of our operating segments in ways that add value for all customers who select Transcat as their source for test and measurement equipment and/or calibration and laboratory instrument services. We believe our combined Service and Distribution segment offerings, experience, technical expertise and quality-oriented, integrity-based approach create a unique and compelling value proposition for our customers. We strive to differentiate ourselves within the markets we serve and build barriers to competitive entry by offering a broad range of the best products and services, and integrating those products and services to benefit our customers’ operations.

Annual Reports

Get access to Transcat’s annual reports, read meeting transcripts and view annual report presentations

Earnings Releases

View Transcat’s earnings releases, listen to presentation webcasts or view the presentation slides

Corporate Governance

View Transcat's corporate governance guidelines, board of directors, executive officers and senior management

Recent Company News

Transcat Reports Record First Quarter Results on 23% Revenue Growth and Solid Gross Margin Expansion

  • Consolidated revenue of $47.8 million up 22.8% from prior year
  • Service segment revenue grew 20% and gross margin expanded 540 basis points to 31.8%; organic revenue grew 16.6%
  • Distribution segment revenue grew 27% and gross margin expanded 260 basis points to 23.6%
  • Adjusted EBITDA of $6.1 million, up 75% from prior year

ROCHESTER, NY, July 27, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its first quarter ended June 26, 2021 (the “first quarter”) of fiscal year 2022, which ends March 26, 2022 (“fiscal 2022”). Results include the previously reported acquisitions of Bio Tek Services, Inc. (“Bio Tek”) effective December 16, 2020 and Upstate Metrology (“Upstate”) effective April 29, 2021.

Transcat Announces First Quarter Fiscal Year 2022 Conference Call and Webcast

ROCHESTER, NY, July 14, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its first quarter fiscal year 2022 results after the close of financial markets on Tuesday, July 27, 2021.

The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow.

Transcat Reports Record Revenue, Operating Income and Cash Flow for Fourth Quarter and Full Year Fiscal 2021

  • Consolidated fourth quarter revenue of $48.8 million up 6.6% from prior year; full year revenue slightly above prior year
  • Service segment fourth quarter organic revenue grew 10% and gross margin expanded 500 basis points to 33.9%
  • Service segment surpassed $100 million in revenue and 30% gross margin milestones for the full year
  • Record full year operating income and operating cash flow of $11.1 million and $23.6 million, respectively

For further information, please contact:

Mark A. Doheny
CFO
35 Vantage Point Drive
Rochester, NY 14624
Phone: 585.484.1350
Email: mark.doheny@transcat.com